Key result
Maternal antiarrhythmics can slow fetal heart rate and reverse lethal complications of fetal tachycardia.
Why the study?
Sustained fetal tachycardia can cause congestive heart failure, hydrops, and fetal death, and treatment with maternal antiarrhythmic medications has recently shown success.
Case Report
Maternal antiarrhythmics may reverse fetal tachycardia complications; hypothesis-generating and requires prospective trials before adoption.
The presence of sustained tachycardia in a fetus can result in congestive heart failure, hydrops, and eventual fetal death. With the increased use of advanced technology in routine obstetric practice, fetal tachycardias are being diagnosed with greater frequency. Recently, administration of antiarrhythmic medications to the mother has been successful in slowing the fetal heart rate and preventing or reversing potentially lethal complications in the fetus. The medications that have been used to treat fetal tachycardia and their potential effects on the mother are discussed. A case study and nursing protocol are presented.
No takes yet. Share an insight, caveat, or question.
Funk et al. (1986) conducted a case report in Fetal tachycardia. Antiarrhythmic medications was evaluated. Administration of antiarrhythmic medications to the mother can successfully slow the fetal heart rate and prevent or reverse potentially lethal complications of fetal tachycardia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: